CITEseq analysis of human CSF cells in Multiple sclerosis
Direct links to NCBI, no account and no request form: the whole study as GSE286068_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 26 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA1207574 and SRA study SRP555878. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 24 samples.
4 replicated groups read from 26 sample titles; they account for 24 of them. Check it against the sample list below before relying on it.
- GSM8717331 CSF cells, SP-MS1
- GSM8717332 CSF cells, HD1
- GSM8717333 CSF cells, PP-MS1
- GSM8717334 CSF cells, RR-MS1
- GSM8717335 CSF cells, RR-MS2
- GSM8717336 CSF cells, PP-MS2
- GSM8717337 CSF cells, NIND1
- GSM8717338 CSF cells, HD2
- GSM8717339 CSF cells, RR-MS3
- GSM8717340 CSF cells, HD3
- GSM8717341 CSF cells, PP-MS3
- GSM8717342 CSF cells, PP-MS4
- GSM8717343 CSF cells, PP-MS5
- GSM8717344 CSF cells, HD4
- GSM8717345 CSF cells, RR-MS4
- GSM8717346 multiplexed CSF cells1
- GSM8717347 multiplexed CSF cells2
- GSM8717348 multiplexed CSF cells3
- GSM8717349 multiplexed CSF cells4
- GSM8717350 multiplexed CSF cells5
- GSM8717351 multiplexed CSF cells6
- GSM8717352 multiplexed CSF cells7
- GSM8717353 multiplexed CSF cells8
- GSM8804804 multiplexed CSF cells9
- GSM8804805 multiplexed CSF cells10
- GSM8804806 multiplexed CSF cells11
- GSE309593 Longitudinal Analysis of Multiple Myeloma: Therapeutic Response and Immune Microenvironment Dynamics in the Context of Tumor Heterogeneity [CITE-Seq] 91 samples
- GSE246342 CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy I 18 samples
- GSE272993 Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8 T cells [dataset 1] 360 samples
- GSE318420 Immunosuppressive monocytes are enriched in hepatocellular carcinoma patients with liver dysfunction in a phase II trial of combination sorafenib and nivolumab 210 samples
- GSE281556 Lysosomal sequestration of PARP inhibitors drives heterogeneous accumulation in ovarian cancer to increase efficacy 204 samples
- GSE327727 D-SPIN constructs regulatory network models from scRNA-seq revealing organizing principles of perturbation response 194 samples
- GSE317605 A Phase II Trial of Pembrolizumab plus Granulocyte Macrophage Colony Stimulating Factor in Advanced Biliary Cancer [CITE-Seq] 168 samples
- GSE270387 Single cell profiling of peripheral blood mononuclear cells in diverse men with prostate cancer reveals lethal disease-associated immune signatures 165 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.